Predictive factors for posttransplant diabetes mellitus within one-year of liver transplantation

Transplantation

Volumn 85, Issue 10, 2008, Pages 1436-1442

  Oufroukhi, Loubna ^a   Kamar, Nassim ^a,b   Muscari, Fabrice ^a   Lavayssiére, Laurence ^a   Guitard, Joëlle ^a   Ribes, Davis ^a   Esposito, Laure ^a   Alric, Laurent ^c   Hanaire, Héléne ^d   Rostaing, Lionel ^a,b  

^a CHU RANGUEIL   (France)

^b INSERM   (France)

^c institut universitaire du cancer   (France)

^d CHURangueil   (France)

Author keywords

Alcohol; Body mass index; Glycemia; Liver transplantation; Posttransplant diabetes mellitus; Steroids

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BODY MASS; COLD ISCHEMIA; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; POSTTRANSPLANT DIABETES MELLITUS; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SURVIVAL; UNIVARIATE ANALYSIS; GENETICS; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY;

ADULT; BODY MASS INDEX; DIABETES MELLITUS; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 48649089875     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31816f1b7c     Document Type: Article

References (37)

1. Cosio FG, Pesavento TE, Osei K, et al. Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001; 59: 732.
2. Bloom RD, Rao V, Weng F, et al. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J AmSoc Nephrol 2002; 13: 1374.
3. Fabrizi F, Martin P, Dixit V, et al. Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: Meta-analysis of clinical studies. Am J Transplant 2005; 5: 2433.
4. Kamar N, Mariat C, Delahousse M, et al. Diabetes mellitus after kidney transplantation: A French multicentre observational study. Nephrol Dial Transplant 2007; 22: 1986.
5. Baid S, Cosimi AB, Farrell ML, et al. Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitisCvirus allograft hepatitis and impact on mortality. Transplantation 2001; 72: 1066.
6. Khalili M, Lim JW, Bass N, et al. New onset diabetes mellitus after liver transplantation: The critical role of hepatitis C infection. Liver Transpl 2004; 10: 349.
7. Al Dosary AA, Ramji AS, Elliott TG, et al. Post-liver transplantation diabetes mellitus: An association with hepatitis C. Liver Transpl 2002; 8: 356.
8. Saliba F, Lakehal M, Pageaux GP, et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: An observational multicenter study. Liver Transpl 2007; 13: 136.
9. Thuluvath PJ. Is there a link between hepatitis C virus and new onset of diabetes mellitus after liver transplantation? Liver Transpl 2007; 13: 5.
10. Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178.
11. Hjelmesaeth J, Hartmann A, Leivestad T, et al. The impact of earlydiagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006; 69: 588.
12. Burroughs TE, Swindle J, Takemoto S, et al. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation 2007; 83: 1027.
13. John PR, Thuluvath PJ. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl 2002; 8: 708.
14. Marchetti P. New-onset diabetes after liver transplantation: From pathogenesis to management. Liver Transpl 2005; 11: 612.
15. Moon JI, Barbeito R, Faradji RN, et al. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up. Transplantation 2006; 82: 1625.
16. Levy G, Grazi GL, Sanjuan F, et al. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. Liver Transpl 2006; 12: 1464.
17. Vincenti F, Friman S, Scheuermann E, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007; 7: 1506.
18. Joss N, Staatz CE, Thomson AH, et al. Predictors of new onset diabetes after renal transplantation. Clin Transplant 2007; 21: 136.
19. Hjelmesaeth J, Hartmann A, Kofstad J, et al. Tapering off prednisolone and cyclosporin the first year after renal transplantation: The effect on glucose tolerance. Nephrol Dial Transplant 2001; 16: 829.
20. Parikh CR, Klem P, Wong C, et al. Obesity as an independent predictor of posttransplant diabetes mellitus. Transplant Proc 2003; 35: 2922.
21. Rostaing L, Cantarovich D, Mourad G, et al. Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation 2005; 79: 807.
22. American Diabetes Association. Standards of medical care in diabetes- 2007. Diabetes Care 2007; 30(suppl 1): S4.
23. Davidson JA, Wilkinson A. International expert panel on new-onset diabetes after transplantation. New-onset diabetes after transplantation 2003 international consensus guidelines: An endocrinologist's view. Diabetes Care 2004; 27: 805.
24. Mirabella S, Brunati A, Ricchiuti A, et al. New-onset diabetes after liver transplantation. Transplant Proc 2005; 37: 2636.
25. Saab S, Shpaner A, Zhao Y, et al. Prevalence and risk factors for diabetes in moderate term survivors of liver transplantation. Am J Transplant 2006; 6: 1890.
26. Yoo HY, Thuluvath PJ. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation 2002; 74: 1007.
27. John PR, Thuluvath PJ. Outcome of liver transplantation in patients with diabetes mellitus. A case-control study. Hepatology 2001; 34: 889.
28. Heisel O, Heisel R, Balshaw R, et al. New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis. Am J Transplant 2004; 4: 583.
29. Tueche SG. Diabetes mellitus after liver transplant new etiologic clues and cornerstones to understanding. Transplant Proc 2003; 35: 1466.
30. Steinmuller TH, Stockmann M, Bechstein WO, et al. Liver transplantation and diabetes mellitus. Exp Clin Endocrinol Diabetes 2000; 108: 401.
31. Chan JC, Cockram CS, Critchley JA. Drug-induced disorders of glucose metabolism. Mechanisms and management. Drug Saf 1996; 15: 135.
32. Pageaux GP, Calmus Y, Boillot C, et al. Steroid withdrawal at day 14 after liver transplantation: A double-blind, placebo-controlled study. Liver Transpl 2004; 10: 1454.
33. Moench C, Barreiros AP, Schuchmann M, et al. Tacrolimus monotherapy without steroids after liver transplantation-a prospective randomized double-blinded placebo-controlled trial. Am J Transplant 2007; 7: 1616.
34. Figueras J, Prieto M, Bernardos A, et al. Daclizumab induction and maintenance steroid-free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allografts. Transpl Int 2006; 19: 641.
35. Eason JD, Nair S, Cohen AJ, et al. Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy. Transplantation 2003; 75: 1396.
36. Dumortier J, Bernard S, Bouffard Y, et al. Conversion from tacrolimus to cyclosporine in liver transplanted patients with diabetes mellitus. Liver Transpl 2006; 12: 659.
37. Haddad EM, McAlister VC, Renouf E, et al. Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev 2006; 4: CD005161.